Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal.

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:

Wednesday, June 13, 2018

Severe, active atopic eczema linked to cardiovascular outcomes

Once again proving that the medical world is woefully uniformed about stroke.  The WHO reclassified stroke in 2006, now a neurological disease not cardiovascular disease.
Reuters Health News
Adults with severe and predominantly active atopic eczema face an increased long-term risk of cardiovascular disease (CVD), according to new findings.
"Adult patients with eczema were 10%-20% more likely to experience non-fatal CVD than people without eczema, and . . . risk increased with more severe and active disease," Dr. Sinead M. Langan of the London School of Hygiene and Tropical Medicine, in the UK, told Reuters Health by email.
About 10% of adults have atopic eczema, and prevalence is increasing globally, Dr. Langan and her team note in The BMJ, online May 23. Systemic inflammation due to the skin condition could be associated with other illnesses, they add, including CVD. But studies of the association between atopic eczema and CVD have had conflicting results.
To further investigate the association, and determine whether atopic eczema severity or activity might influence risk, the researchers compared more than 387,000 patients with atopic eczema and 1.5 million matched controls. Follow-up was a median 5.1 years.
Stroke risk was increased by 20% among patients with severe atopic eczema. Those with severe disease were also at 40% to 50% greater risk of myocardial infarction, unstable angina, atrial fibrillation, and death due to CVD, and had a 70% higher risk of heart failure.
Patients whose eczema was active more than half of the time at follow-up also had an increased risk of CVD-related outcomes.
"Clinically, patients with severe atopic eczema often have poor sleep and experience high levels of stress, which may help to explain the association," Dr. Langan said.
More research is needed on the mechanism behind the association, she added, and whether eczema treatments may modify CVD risk.
—Anne Harding

No comments:

Post a Comment